Symptomatic hypokalemia associated with infliximab in a patient with Crohn's disease

Inflamm Bowel Dis. 2006 Oct;12(10):1010-1. doi: 10.1097/01.mib.0000235102.16855.4a.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Crohn Disease / blood
  • Crohn Disease / drug therapy*
  • Humans
  • Hypokalemia / chemically induced*
  • Infliximab
  • Male
  • Periodicity

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab